Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice (EMTM)

Tabula Rasa HealthCare

Status: Completed

Conditions: Medication Therapy Management; Pharmacogenomics

Treatments: Other: Medication therapy management

Study type: Interventional

Funder types: Industry

Identifiers

NCT02748148

MTM-309

Details and patient eligibility

About

The purpose of this study is to identify challenges and successes associated with implementing an enhanced medication therapy management service in primary care practice.

Full description

The specific aim of this study is to implement a Medication Therapy Management (MTM) service in primary care that is enhanced by the incorporation of pharmacogenomics (PGx) and medication risk mitigation (MRM) factor technology and is standardized by a systematic approach to evidence- and personalized-based medicine. The primary objective is to implement the systematic approach to delivering an enhanced MTM service in a primary care setting. Secondary objectives include: determine how successful the communication between prescriber and pharmacist is within implementing the service, determine how PGx testing can be incorporated into primary care prescribers' daily work flow, determine if patients are receptive to PGx testing, determine how satisfied prescribers are with an enhanced MTM clinical service and their confidence to conduct on their own, and determine if enhanced MTM optimizes or changes drug therapy for patients.

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Receiving primary health care from Elmwood Family Physicians; and
• Medicare beneficiary; and
• Currently prescribed at least 7 medications, or prescriber feels patient would benefit from enhanced medication therapy management, or actual or suspected medication-related problem

Exclusion criteria

• Not willing to participate in the study and sign informed consent; or
• Non-English speaking or designated surrogate as translator not available

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Medication therapy management

Experimental group

Description:

Medication therapy management service that is enhanced by the incorporation of pharmacogenomics and medication risk mitigation factor technology

Treatment:

Other: Medication therapy management